Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 14376 - 14378 of 14378 in total
Denibulin is a novel small molecule Vascular Disrupting Agent under development by MediciNova for treatment of solid tumor cancers.
Investigational
AEOL 10150 is developed by Aeolus as a therapeutic agents based on its proprietary small molecule catalytic antioxidants.
Investigational
Investigational
Displaying drugs 14376 - 14378 of 14378 in total